197 related articles for article (PubMed ID: 37938820)
1. Mendelian Randomization as a Tool for Cardiovascular Research: A Review.
Levin MG; Burgess S
JAMA Cardiol; 2024 Jan; 9(1):79-89. PubMed ID: 37938820
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization for cardiovascular diseases: principles and applications.
Larsson SC; Butterworth AS; Burgess S
Eur Heart J; 2023 Dec; 44(47):4913-4924. PubMed ID: 37935836
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the current state of Mendelian randomization studies: a protocol for a systematic review on methodological and clinical aspects using neurodegenerative disorders as outcome.
Grover S; Del Greco M F; König IR
Syst Rev; 2018 Sep; 7(1):145. PubMed ID: 30249280
[TBL] [Abstract][Full Text] [Related]
4. Extending Causality Tests with Genetic Instruments: An Integration of Mendelian Randomization with the Classical Twin Design.
Minică CC; Dolan CV; Boomsma DI; de Geus E; Neale MC
Behav Genet; 2018 Jul; 48(4):337-349. PubMed ID: 29882082
[TBL] [Abstract][Full Text] [Related]
5. Mendelian Randomization as an Approach to Assess Causality Using Observational Data.
Sekula P; Del Greco M F; Pattaro C; Köttgen A
J Am Soc Nephrol; 2016 Nov; 27(11):3253-3265. PubMed ID: 27486138
[TBL] [Abstract][Full Text] [Related]
6. 'Mendelian randomization': an approach for exploring causal relations in epidemiology.
Gupta V; Walia GK; Sachdeva MP
Public Health; 2017 Apr; 145():113-119. PubMed ID: 28359378
[TBL] [Abstract][Full Text] [Related]
7. Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer.
Wade KH; Yarmolinsky J; Giovannucci E; Lewis SJ; Millwood IY; Munafò MR; Meddens F; Burrows K; Bell JA; Davies NM; Mariosa D; Kanerva N; Vincent EE; Smith-Byrne K; Guida F; Gunter MJ; Sanderson E; Dudbridge F; Burgess S; Cornelis MC; Richardson TG; Borges MC; Bowden J; Hemani G; Cho Y; Spiller W; Richmond RC; Carter AR; Langdon R; Lawlor DA; Walters RG; Vimaleswaran KS; Anderson A; Sandu MR; Tilling K; Davey Smith G; Martin RM; Relton CL;
Cancer Causes Control; 2022 May; 33(5):631-652. PubMed ID: 35274198
[TBL] [Abstract][Full Text] [Related]
8. [Mendelian randomization approach, used for causal inferences].
Wang LN; Zhang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):547-552. PubMed ID: 28468080
[TBL] [Abstract][Full Text] [Related]
9. Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization.
Katikireddi SV; Green MJ; Taylor AE; Davey Smith G; Munafò MR
Addiction; 2018 Apr; 113(4):764-774. PubMed ID: 28921935
[TBL] [Abstract][Full Text] [Related]
10. From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment.
Benn M; Nordestgaard BG
Cardiovasc Res; 2018 Jul; 114(9):1192-1208. PubMed ID: 29471399
[TBL] [Abstract][Full Text] [Related]
11. Mendelian Randomization in Cardiovascular Research: Establishing Causality When There Are Unmeasured Confounders.
Bell KJL; Loy C; Cust AE; Teixeira-Pinto A
Circ Cardiovasc Qual Outcomes; 2021 Jan; 14(1):e005623. PubMed ID: 33397121
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
[TBL] [Abstract][Full Text] [Related]
14. Modifiable environmental exposure and risk of rheumatoid arthritis-current evidence from genetic studies.
Jiang X; Alfredsson L
Arthritis Res Ther; 2020 Jun; 22(1):154. PubMed ID: 32571398
[TBL] [Abstract][Full Text] [Related]
15. Mendelian Randomization: Concepts and Scope.
Richmond RC; Davey Smith G
Cold Spring Harb Perspect Med; 2022 Jan; 12(1):. PubMed ID: 34426474
[TBL] [Abstract][Full Text] [Related]
16. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy.
Rees JMB; Wood AM; Burgess S
Stat Med; 2017 Dec; 36(29):4705-4718. PubMed ID: 28960498
[TBL] [Abstract][Full Text] [Related]
17. Mendelian randomization: application to cardiovascular disease.
Timpson NJ; Wade KH; Smith GD
Curr Hypertens Rep; 2012 Feb; 14(1):29-37. PubMed ID: 22161218
[TBL] [Abstract][Full Text] [Related]
18. Investigating the transparency of reporting in two-sample summary data Mendelian randomization studies using the MR-Base platform.
Woolf B; Di Cara N; Moreno-Stokoe C; Skrivankova V; Drax K; Higgins JPT; Hemani G; Munafò MR; Davey Smith G; Yarmolinsky J; Richmond RC
Int J Epidemiol; 2022 Dec; 51(6):1943-1956. PubMed ID: 35383846
[TBL] [Abstract][Full Text] [Related]
19. Mendelian randomization analyses in ocular disease: a powerful approach to causal inference with human genetic data.
Li J; Li C; Huang Y; Guan P; Huang D; Yu H; Yang X; Liu L
J Transl Med; 2022 Dec; 20(1):621. PubMed ID: 36572895
[TBL] [Abstract][Full Text] [Related]
20. Mendelian randomization for nephrologists.
Dobrijevic E; van Zwieten A; Kiryluk K; Grant AJ; Wong G; Teixeira-Pinto A
Kidney Int; 2023 Dec; 104(6):1113-1123. PubMed ID: 37783446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
